Recent Updates
Recently added Catalysts

HOOKIPA Pharma Inc.

HOOKFDA catalysts, PDUFA dates & pipeline intelligence
$1.13
▲ +0.01 · +0.48%

Last traded Jun 2, 2026. This price is not current.

Financials

Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Quarterly Cash
Unlock full HOOK financials and dilution scoring
Quarter by quarter figures, cash trend and dilution risk.
Institutional-grade data · Cancel anytime
52W LOW $0.7252W HIGH $5.66
Volume
9.27 K
Value Traded
10.64 K
Short % Float
1.87%
Days to Cover
1.0
-6.63%Week
-26.93%1 Month
-43.6%3 Month
-55.3%6 Month
-99.21%5 Year
-99.41%All Time

Cash Data

Unlock HOOK cash and runway
  • Monthly Burn
  • Burn Trend
  • Dilution Risk
  • SEC Filing

Key Stats

Market Cap
10.25 M
EPS (TTM)
-5.93
P/E Ratio
-
Ent. Value
-29.53 M
Total Shares
9.80 M
Float Shares
6.85 M
Insiders
42.75%
Institutions
20.20%

Upcoming Catalysts

FDA decisions, readouts and PDUFA dates · scored by probability of approval

Catalyst Drug / Treatment Stage Prob. of Approval Description Drug Type Therapeutic Area Source
Unlock every HOOK catalyst date and PoA score
Every FDA decision, readout and PDUFA date, with drug type, therapeutic area and a PoA score you can trade on.
Institutional-grade data · Cancel anytime
PoA blends historical approval base rates, trial design score and FDA review track record.

HOOK Catalyst Timeline

Dated clinical, regulatory and corporate events for HOOKIPA Pharma Inc.

Unlock the full HOOK catalyst timeline
Every PDUFA date, readout, approval and corporate move, tiered by market impact and updated daily.
Institutional-grade data · Cancel anytime

Past FDA Catalysts and PDUFA Decisions

How HOOK actually traded into and out of each decision

Date Drug Catalyst Stage Reaction Event Move % Best Trade %
No matching catalysts
Unlock all HOOK historical catalysts
Institutional-grade data · Cancel anytime
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision

Drug Pipeline Intelligence

Pipeline Score
Pipeline Value
Valuation Signal
2
Drugs Scored
rNPV / MCap
Top Drug
Showing 2 of 4 assets
DrugIndicationPhasePTRSrNPVStatusEnrollVelocityDesignEst. CompletionML SignalLast Change
HB-201 administration Small moleculeCompletedNCT04180215HPV-Related Squamous Cell CarcinomaPhase 1/2 COMPLETED 198Jan 9, 2025
Low dose HB-101 VaccineCompletedNCT03629080Cytomegalovirus (CMV) InfectionPhase 2 COMPLETED 83Jun 22, 2022
Unlock the HOOK pipeline intelligence model
PTRS, rNPV, enrollment velocity, trial design quality and ML risk signals for every asset above.
Institutional-grade data · Cancel anytime

Clinical Trial Results

Readouts, endpoints and source filings for every HOOK program

Drug Name Indication Phase Date Trial Results SummaryTitleSource
HB-200 recurrent/metastatic human papillomavirus 16 positive (HPV16+) head and neck cancerPhase 22024-06-04ORR: 37%; CR: 11%; DCR: 69%; subset ORR: 53%; subset CR: 18%; subset DCR: 82%; median follow up: 8.4 monthsRead MoreHOOKIPA Pharma Announces Updated Phase 2 Clinical Data at the American Society for Clinical Oncology 2024 Annual Meeting Encouraging clinical activity with observed deepening of responses in 35 evaluable first line head Read More
Scroll for more · summaries link to the source press release
Unlock every HOOK trial readout
Institutional-grade data · Cancel anytime

Inside Trades

Unlock HOOK insider buying and selling
Monthly insider buys and sells against the stock price, with the insider sentiment reading.
Institutional-grade data · Cancel anytime
InsiderSideSharesPriceValueDate
Peters MalteDirector, Officer (Chief Executive Officer)Sell -25,172 54,347 held$0.82 08/19/2025
Unlock the full HOOK insider trade log
Institutional-grade data · Cancel anytime

Hedge Fund 13F Activity

Hedge Funds invested in HOOK

Fund % of Portfolio Current MV Shares Owned Activity
BAKER BROS. ADVISORS 0 % 1.02 M 812.81 K
Unlock every fund holding HOOK
Every 13F position with quarter over quarter share flow and average entry price.
Institutional-grade data · Cancel anytime
Unlock hedge fund flows in HOOK
Shares held by hedge funds each quarter, and who bought or sold.

Ownership Trends

Sign in to see HOOK ownership
Insider and institutional ownership, quarter by quarter.

HOOK Short Interest

Shares sold short, counted twice a month.

1.87%
Short % of Float
of tradable shares sold short
10.6K
Shares Sold Short
0.0% vs prior count
1.0 Low
Days to Cover
trading days of normal volume to buy every short share back
23.9K
Avg Daily Volume
the average used for days to cover
Unlock HOOK short interest history
Two years of days to cover and shares sold short, with every count and its change.
Institutional-grade data · Cancel anytime

Options Data

Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg

Option Chain Statistics

ExpiryCall VolPut VolVol P/CCall OIPut OIOI P/CIV CallIV Call OI-WtdIV Call Vol-WtdIV PutIV Put OI-WtdIV Put Vol-Wtd
2027-01-15
Unlock HOOK option chain statistics
Per-expiry call and put volume, open interest, put-call ratios and implied volatility.
Institutional-grade data · Cancel anytime

Real-Time Option Chain

CallsStrikePuts
LastVolOILastVolOI
No data available
Unlock the live HOOK option chain
Live calls and puts by strike: last price, volume and open interest for every expiry.
Institutional-grade data · Cancel anytime

Calls vs Puts by Expiry

CallsPutsLog scale
Unlock HOOK options analytics
Institutional-grade data · Cancel anytime

Competitive positioning

How HOOK ranks across every disease it competes in

Competitive Position is a premium feature
See how HOOK ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial

HOOK News

About HOOKIPA Pharma Inc.

Founded2019
BIOPHARMAWATCH ELITE PLUS
Trade the next HOOK catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime